首页> 外文会议>International conference of molecular simulations and applied informatics technologies >Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors
【24h】

Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors

机译:基于结构的虚拟筛选,用于鉴定新型11β-HSD1抑制剂

获取原文

摘要

Structure-based pharmacophore models were built by using LigandScout and used for virtual screening of the SPECS database to identify new potential 11β-HSD1 inhibitors. As a refinement of the results obtained from virtual 3D pharmacophore screening, the best fitting virtual hits were subjected to docking study. The resulting compounds were tested in an enzyme assay and revealed several compounds with novel scaffolds that show sub-micromolar activity and high selectivity for 11β-HSD1 against 11β-HSD2.
机译:通过使用LigandScout建造了基于结构的药效模型,并用于虚拟筛选规范数据库以识别新的潜在11β-HSD1抑制剂。作为从虚拟3D Pharmacore筛查获得的结果的改进,对解码研究进行了最佳拟合虚拟命中。在酶测定中测试所得化合物,并揭示了几种具有新型支架的化合物,其显示亚微摩尔活性和11β-HSD1对11β-HSD2的高选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号